Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9181 USD | -8.14% | -19.46% | -84.31% |
May. 29 | Augmedix Appoints Alex Stinard as Chief Clinical AI Officer | CI |
May. 14 | Maxim Downgrades Augmedix to Hold From Buy | MT |
Financials (USD)
Sales 2024 * | 53.2M | Sales 2025 * | 66.58M | Capitalization | 44.96M |
---|---|---|---|---|---|
Net income 2024 * | -29M | Net income 2025 * | -25M | EV / Sales 2024 * | 0.75 x |
Net cash position 2024 * | 4.96M | Net cash position 2025 * | - | EV / Sales 2025 * | 0.68 x |
P/E ratio 2024 * |
-1.68
x | P/E ratio 2025 * |
-1.93
x | Employees | 1,430 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.7% |
Latest transcript on Augmedix, Inc.
1 day | -8.14% | ||
1 week | -19.46% | ||
1 month | -66.12% | ||
3 months | -79.13% | ||
6 months | -82.61% | ||
Current year | -84.31% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Shakil
FOU | Founder | 40 | 11-12-31 |
Chief Executive Officer | 65 | 18-05-31 | |
Paul Ginocchio
DFI | Director of Finance/CFO | 55 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Laurie McGraw
BRD | Director/Board Member | 60 | 22-03-08 |
Margie Traylor
BRD | Director/Board Member | 60 | 21-04-30 |
Robert Faulkner
BRD | Director/Board Member | 61 | 23-04-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.52% | 4 M€ | -5.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.9181 | -8.14% | 816,510 |
24-05-30 | 0.9995 | -12.32% | 846,639 |
24-05-29 | 1.14 | +3.64% | 786,773 |
24-05-28 | 1.1 | -3.51% | 515,753 |
24-05-24 | 1.14 | +1.79% | 713,708 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.31% | 44.96M | |
+12.50% | 68.79B | |
+7.35% | 17.45B | |
+20.68% | 13.58B | |
+8.66% | 13.35B | |
+12.48% | 9.8B | |
-20.94% | 6.74B | |
-4.74% | 5.95B | |
+2.67% | 5.23B | |
-3.21% | 4.85B |
- Stock Market
- Equities
- AUGX Stock